Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Landau

Showing results (411-420 of 428) with videos related to

Pageof 43
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 17, 2026
Contributions of the Alzheimer's Disease Neuroimaging Initiative to advancing AD research: a targeted review of recent publicationsDallas P Veitch, Melanie J Miller, Shaveta Kanoria, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 9, 2022
Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community-engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4Michael W Weiner, Dallas P Veitch, Melanie J Miller, et al.
Cell Stem Cell|October 6, 2023
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PDAgnete Kirkeby, Jenny Nelander, Deirdre B Hoban, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 6, 2024
The POINTER Imaging baseline cohort: Associations between multimodal neuroimaging biomarkers, cardiovascular health, and cognitionTheresa M Harrison, Tyler Ward, Jacinda Taggett, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 24, 2026
Features predicting data exclusion in imaging studies of Alzheimer's diseaseShaney Flores, Jalen Scott, Ruijin Lu, et al.
Cell Reports. Medicine|September 13, 2022
A genetically modified minipig model for Alzheimer's disease with SORL1 haploinsufficiencyOlav M Andersen, Nikolaj Bøgh, Anne M Landau, et al.
The Lancet. Neurology|October 25, 2020
Amyloid-PET and <sup>18</sup>F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementiasGaël Chételat, Javier Arbizu, Henryk Barthel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 31, 2021
Alzheimer's disease research progress in Australia: The Alzheimer's Association International Conference Satellite Symposium in SydneyClaire E Sexton, Kaarin J Anstey, Filippo Baldacci, et al.
Annals of Neurology|March 17, 2025
Amyloid PET in Sporadic Early- Versus Late-Onset Alzheimer's Disease: Comparison of the LEADS and ADNI CohortsJulien Lagarde, Piyush Maiti, Daniel R Schonhaut, et al.
JAMA|May 20, 2015
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysisRik Ossenkoppele, Willemijn J Jansen, Gil D Rabinovici, et al.
Pageof 43

Showing results (411-420 of 428) with videos related to

Sort By:
Pageof 43
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 17, 2026
Contributions of the Alzheimer's Disease Neuroimaging Initiative to advancing AD research: a targeted review of recent publicationsDallas P Veitch, Melanie J Miller, Shaveta Kanoria, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 9, 2022
Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community-engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4Michael W Weiner, Dallas P Veitch, Melanie J Miller, et al.
Cell Stem Cell|October 6, 2023
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PDAgnete Kirkeby, Jenny Nelander, Deirdre B Hoban, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 6, 2024
The POINTER Imaging baseline cohort: Associations between multimodal neuroimaging biomarkers, cardiovascular health, and cognitionTheresa M Harrison, Tyler Ward, Jacinda Taggett, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 24, 2026
Features predicting data exclusion in imaging studies of Alzheimer's diseaseShaney Flores, Jalen Scott, Ruijin Lu, et al.
Cell Reports. Medicine|September 13, 2022
A genetically modified minipig model for Alzheimer's disease with SORL1 haploinsufficiencyOlav M Andersen, Nikolaj Bøgh, Anne M Landau, et al.
The Lancet. Neurology|October 25, 2020
Amyloid-PET and <sup>18</sup>F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementiasGaël Chételat, Javier Arbizu, Henryk Barthel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 31, 2021
Alzheimer's disease research progress in Australia: The Alzheimer's Association International Conference Satellite Symposium in SydneyClaire E Sexton, Kaarin J Anstey, Filippo Baldacci, et al.
Annals of Neurology|March 17, 2025
Amyloid PET in Sporadic Early- Versus Late-Onset Alzheimer's Disease: Comparison of the LEADS and ADNI CohortsJulien Lagarde, Piyush Maiti, Daniel R Schonhaut, et al.
JAMA|May 20, 2015
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysisRik Ossenkoppele, Willemijn J Jansen, Gil D Rabinovici, et al.
Pageof 43